J&J’s Nicorette Becomes World’s First Licensed Vaping And Smoking Cessation Therapy

J&J's OTC nicotene replacemnt therapy brand Nicorette goes from strength to strength in the UK with a world-first approval from the country's medicines regulator for its Quickmist product for vaping cessation. 

Approved stamp

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved the use of Johnson & Johnson Nicorette QuickMist Mouthspray as a way for people to give up vaping.

With this approval, Nicorette QuickMist Mouthspray becomes the world’s first nicotine replacement therapy (NRT) for both vaping and smoking cessation.

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United Kingdom

More from Europe